International health care products major Covidien’s (NYSE:COV - News) Solitaire FR revascularization device has been cleared for investigational use in the Interventional Management of Stroke (“IMS ...
Covidien (Mansfield, Massachusetts) reported that the Solitaire FR revascularization device has been cleared by FDA. The device is intended to restore blood flow to the brain in patients suffering ...
March 6, 2012 — The US Food and Drug Administration (FDA) has granted approval for a new clot retrieval system, the Solitaire Flow Restoration (FR) device (Covidien), the company has announced. The ...
Covidien gained Canadian approval for its Solitaire FR device--courtesy of Covidien Covidien ($COV) is expanding the reach of its Solitaire FR revascularization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback